Skip to main content
logo
Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
13.44
+0.46 (3.54%)
At close: Jul 27, 2026, 4:00 PM EDT
13.23
-0.21 (-1.56%)
Pre-market: Jul 28, 2026, 4:01 AM EDT

Greenwich LifeSciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
197300148135195320
Market Cap Growth
27.54%103.38%9.28%-30.79%-38.95%-30.95%
Enterprise Value
186.77294.23143.61128.17181.82292.68
Last Close Price
13.4421.0111.2310.5215.2024.33

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
37.40850.50162.5620.1714.7811.92
P/TBV Ratio
34.46805.09161.1720.1914.8711.74

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.99-17.49-4.50-1.04-1.02-1.01
Net Debt / EBITDA Ratio
0.480.320.230.751.685.92
Net Debt / FCF Ratio
0.820.620.561.082.176.34
Quick Ratio
2.011.061.2823.7451.2370.63
Current Ratio
2.011.061.2823.7451.2370.63
Return on Equity (ROE)
-773.80%-3068.25%-457.73%-89.30%-39.08%-16.78%
Return on Assets (ROA)
-262.43%-378.67%-318.12%-91.13%-39.52%-16.45%
Return on Invested Capital (ROIC)
--2186390.00%-491973.00%-129608.00%-74384.80%-31883.70%
Return on Capital Employed (ROCE)
-778.58%-3082.46%-463.59%-93.68%-40.16%-16.88%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-6.04%-4.00%-1.30%0.51%0.23%-36.27%
Total Shareholder Return
-6.04%-4.00%-1.30%0.51%0.23%-36.27%
SEC Filings: 10-K · 10-Q